loadpatents
name:-0.037131071090698
name:-0.0063040256500244
name:-0.006350040435791
ZHAI; Yifan Patent Filings

ZHAI; Yifan

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHAI; Yifan.The latest application filed is for "n-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors".

Company Profile
6.5.31
  • ZHAI; Yifan - Suzhou CN
  • Zhai; Yifan - Guangzhou CN
  • Zhai; Yifan - Guilford CT
  • Zhai; Yifan - Rockville MD
  • Zhai, Yifan - Gaithersburg MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
N-(phenylsulfonyl)benzamides And Related Compounds As Bcl-2 Inhibitors
App 20220305034 - ZHAI; Yifan ;   et al.
2022-09-29
Pharmaceutical composition and use thereof
Grant 11,452,716 - Yang , et al. September 27, 2
2022-09-27
Bisdiazabicyclo Compound For Treating And/or Preventing Hepatitis Virus-related Diseases Or Disorders
App 20220296571 - Zhai; Yifan ;   et al.
2022-09-22
Combinations Of Bcl-2/bcl-xl Inhibitors And Related Uses
App 20220296557 - ZHAI; Yifan ;   et al.
2022-09-22
Method And Composition For Predicting Efficacy Of Bcl2/bcl-xl Inhibitors On Cancer
App 20220233558 - ZHAI; Yifan ;   et al.
2022-07-28
Compound for treating osteoarthritis
Grant 11,395,815 - Yang , et al. July 26, 2
2022-07-26
Methods For Cancer Therapy
App 20220193071 - ZHAI; Yifan ;   et al.
2022-06-23
Combination Of Immunotherapies With Mdm2 Inhibitors
App 20220175725 - YANG; Dajun ;   et al.
2022-06-09
Pharmaceutical Combination and Use Thereof
App 20220142975 - Zhai; Yifan ;   et al.
2022-05-12
Combination Product Of A Bcl-2/bcl-xl Inhibitor And A Chemotherapeutic Agent And Use Thereof In The Prevention And/or Treatment Of Diseases
App 20220143039 - YANG; Dajun ;   et al.
2022-05-12
Pharmaceutical Composition Of Mdm2 Inhibitor And Use Thereof For Preventing And/or Treating Disease
App 20220142979 - YANG; Dajun ;   et al.
2022-05-12
Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disorders
Grant 11,298,339 - Zhai , et al. April 12, 2
2022-04-12
Treatment Method With Iap Inhibitor
App 20220047606 - Zhai; Yifan ;   et al.
2022-02-17
Combination Product Of Bcl-2 Inhibitor And Mdm2 Inhibitor And Use Thereof In The Prevention And/or Treatment Of Diseases
App 20220031694 - YANG; Dajun ;   et al.
2022-02-03
Synergistic Antitumor Effect Of Bcl-2 Inhibitor Combined With Rituximab And/or Bendamustine Or Bcl-2 Inhibitor Combined With Chop
App 20210361678 - YANG; Dajun ;   et al.
2021-11-25
Method For Treating Cancer By Combination Of Fak/alk/rosi Inhibitor And Egfr Inhibitor
App 20210330669 - YANG; Dajun ;   et al.
2021-10-28
Method For Treating Cancer By Combination Of Iap Inhibitor And Modulator Of Immune Checkpoint Molecule
App 20210330642 - YANG; Dajun ;   et al.
2021-10-28
Treatment Methods And Biomarkers For Mdm2 Inhibitors
App 20210311020 - ZHAI; Yifan ;   et al.
2021-10-07
Bisdiazabicyclo Compound For Treatment And/or Prevention Of Hepatitis Virus-related Diseases Or Disorders
App 20210290594 - Zhai; Yifan ;   et al.
2021-09-23
Pharmaceutical Compositions And Use Thereof
App 20210275522 - YANG; Dajun ;   et al.
2021-09-09
Mdm2 Inhibitor And A Platinum Compound For Cancer Treatment
App 20210186939 - Zhai; Yifan ;   et al.
2021-06-24
Combination Product Of Bcl-2 Inhibitor And Chemotherapeutic Agent And Use Thereof In The Prevention And/or Treatment Of Diseases
App 20210137949 - YANG; Dajun ;   et al.
2021-05-13
Combination Of Bcl-2/bcl-xl Inhibitors And Chemotherapeutic Agent And Use Thereof
App 20210060039 - YANG; Dajun ;   et al.
2021-03-04
Novel Pharmaceutical Composition And Use Thereof
App 20200297704 - Yang; Dajun ;   et al.
2020-09-24
Combination Of Bcl-2/bcl-xl Inhibitors And Chemotherapeutic Agent And Use Thereof
App 20200297743 - ZHAI; Yifan ;   et al.
2020-09-24
Combination Product Of Bcl-2 Inhibitor Or Bcl-2/bcl-xl Dual Inhibitor And Btk Inhibitor And Use Thereof In The Prevention And/or
App 20200222393 - YANG; Dajun ;   et al.
2020-07-16
Compound For Treating Osteoarthritis
App 20200222366 - Yang; Dajun ;   et al.
2020-07-16
Aryl Urea Compounds In Combination With Other Cytostatic Or Cytotoxic Agents For Treating Human Cancers
App 20120040925 - Carter; Christopher A. ;   et al.
2012-02-16
Methods and compositions for decreasing T-cell activity
Grant 7,964,190 - Ebner , et al. June 21, 2
2011-06-21
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
App 20060247186 - Carter; Christopher A. ;   et al.
2006-11-02
VEGI, an inhibitor of angiogenesis and tumor growth
App 20050214305 - Li, Lu-Yuan ;   et al.
2005-09-29
Apoptosis inducing molecule II and methods of use
App 20040009147 - Ebner, Reinhard ;   et al.
2004-01-15
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
App 20030232765 - Carter, Christopher A. ;   et al.
2003-12-18
Apoptosis inducing molecule II and methods of use
Grant 6,635,743 - Ebner , et al. October 21, 2
2003-10-21
VEGI, an inhibitor of angiogenesis and tumor growth
App 20020111325 - Li, Lu-Yuan ;   et al.
2002-08-15
Apoptosis Inducing Molecule Ii And Methods Of Use
App 20020081647 - EBNER, REINHARD ;   et al.
2002-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed